PMID- 27820950 OWN - NLM STAT- MEDLINE DCOM- 20170606 LR - 20220310 IS - 1552-5783 (Electronic) IS - 0146-0404 (Linking) VI - 57 IP - 14 DP - 2016 Nov 1 TI - The Ingenious Interactions Between Macrophages and Functionally Plastic Retinal Pigment Epithelium Cells. PG - 5945-5953 LID - 10.1167/iovs.16-20604 [doi] AB - PURPOSE: The purpose of this study was to clarify the interactions between macrophages (MPs) and RPE cells in coculture systems to investigate the functional plasticity of RPE cells. METHODS: Adherent peritoneal cells or murine MP cell line Raw 264.7 was cocultured with primary RPE cells taken from C57BL/6 mice, with or without lipopolysaccharide (LPS) or TNF-alpha stimulation. The cytokine levels of the culture supernatants (CSs) were then analyzed with the Bio-Plex murine 23-Plex Panel Assay Kit (Bio-Rad Laboratories). Monocyte chemoattractant protein-1 (MCP-1), IL-6, VEGF, and TNF-alpha in CS were further quantified by ELISA. The expression profiles, in cocultures, of complement-associated genes, TNF-alpha, and angiogenesis-associated genes were analyzed by quantitative real-time PCR. RESULTS: The production of MCP-1, IL-6, and VEGF was synergistically elevated when primary MPs or RAW264.7 cells and RPE cells were cocultured compared with those derived from sole cultures of MPs and RPE cells. The synergistic effect was confirmed without direct cell contact and was more prominent in the presence of LPS or TNF-alpha. TNF-alpha production by MPs was suppressed by RPE cells. Coculture of RPE cells with RAW264.7 cells increased the gene expression of C3, CFB, and VEGF genes, whereas it reduced those of complement regulatory factors CFH, CD59, clusterin, and TNF-alpha and antiangiogenic pigment epithelium-derived factor (PEDF). CONCLUSIONS: Our findings indicate the presence of ingenious interactions between MPs and RPE cells that forces the inflammation and complement activation in the vicinity of RPE cells under pathologic conditions. FAU - Yamawaki, Takahiro AU - Yamawaki T AD - Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. FAU - Ito, Eiko AU - Ito E AD - Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. FAU - Mukai, Atsushi AU - Mukai A AD - Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. FAU - Ueno, Morio AU - Ueno M AD - Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. FAU - Yamada, Jun AU - Yamada J AD - Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. FAU - Sotozono, Chie AU - Sotozono C AD - Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. FAU - Kinoshita, Shigeru AU - Kinoshita S AD - Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. FAU - Hamuro, Junji AU - Hamuro J AD - Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. LA - eng PT - Journal Article PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Animals MH - Cells, Cultured MH - Chemokine CCL2/metabolism MH - Coculture Techniques MH - Cytokines/*metabolism MH - Enzyme-Linked Immunosorbent Assay MH - Epithelial Cells/*metabolism MH - Interleukin-6/metabolism MH - Macrophages/*metabolism MH - Mice MH - Mice, Inbred C57BL MH - Real-Time Polymerase Chain Reaction MH - Retinal Pigment Epithelium/cytology/*metabolism MH - Tumor Necrosis Factor-alpha/metabolism EDAT- 2016/11/08 06:00 MHDA- 2017/06/07 06:00 CRDT- 2016/11/08 06:00 PHST- 2016/11/08 06:00 [entrez] PHST- 2016/11/08 06:00 [pubmed] PHST- 2017/06/07 06:00 [medline] AID - 2582822 [pii] AID - 10.1167/iovs.16-20604 [doi] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):5945-5953. doi: 10.1167/iovs.16-20604.